Filing Details
- Accession Number:
- 0001209191-15-054843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-18 20:42:56
- Reporting Period:
- 2015-06-16
- Filing Date:
- 2015-06-18
- Accepted Time:
- 2015-06-18 20:42:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 827871 | Eagle Pharmaceuticals Inc. | EGRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599743 | L. Steven Krill | C/O Eagle Pharmaceuticals, Inc. 50 Tice Blvd., Suite 315 Woodcliff Lake NJ 07677 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-16 | 5,850 | $8.78 | 5,850 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-16 | 5,850 | $81.60 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-16 | 2,730 | $8.78 | 2,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-16 | 2,730 | $81.60 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-06-16 | 1,400 | $4.42 | 1,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-16 | 1,400 | $81.60 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-16 | 5,850 | $0.00 | 5,850 | $8.78 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-16 | 2,730 | $0.00 | 2,730 | $8.78 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-16 | 1,400 | $0.00 | 1,400 | $4.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,950 | 2021-09-25 | No | 4 | M | Direct | |
| 2,730 | 2022-07-11 | No | 4 | M | Direct | |
| 20,517 | 2023-04-18 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.73 to $82.76, inclusive. The reporting person undertakes to provide to Eagle Pharmaceuticals, Inc., any security holder of Eagle Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $80.73 to $82.76, inclusive.
- 25% of the shares subject to the option vested on September 26, 2012 and the remainder shall vest in equal monthly installments over a period of three years.
- 25% of the shares subject to the option vested on July 12, 2013 and the remainder shall vest in equal monthly installments over a period of three years.
- 25% of the shares subject to the option vested on April 19, 2014 and the remainder shall vest in equal monthly installments over a period of three years.
Billionaire Hedge Funds
